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COPD is a common disease characterized by airflow
obstruction and loss of gas exchange surface. COPD is a
high prevalent disease among elderly and represent an
important cause of morbidity and mortality. Despite
being a treatable and preventable disease, the prevalence
of COPD continues to rise because of the worldwide
epidemic diffusion of cigarette smoking. COPD is asso-
ciated with enormous healthcare costs. Scientific evi-
dences demonstrated that COPD is a systemic disease,
characterized by a high prevalence of co-morbid condi-
tions such as cardiovascular disease, muscle wasting and
osteoporosis, probably linked by a common mechanism
related to the systemic inflammatory response. Depres-
sion, anxiety and malnutrition are also common among
elderly COPD patients [1]. These factors not only affect
quality of life (QoL) but also decrease patients’ compli-
ance to therapy. Malnutrition is an independent predic-
tor of mortality and poor outcome. Pulmonary Function
Test (PFT) is essential for the diagnosis of COPD, but
it’s still unclear if criteria defining airflow obstruction
commonly used in adults (GOLD guidelines [2]) have
the same specificity if applied in elderly patients, thus
resulting in over-diagnosis. However, older patients have
an impaired symptoms perception, therefore COPD
could also be under-diagnosed in this population. Acute
exacerbations result in worsening of symptoms and
often require additional treatment and hospitalization,
and may cause a faster decline in lung function and
QoL. The management of elderly patients with COPD
should encompass a multidisciplinary approach. In addi-
tion to the assessment of lung ventilatory performance
and functional impairment, an evaluation of patients’
nutritional status and mental health should be underta-
ken. Significant underlying co-morbidities should also
be evaluated and treated to improve outcome. Specific
therapy for COPD should start with cessation of expo-
sure to tobacco smoke, the most important risk factor.
Smoking cessation rates in the elderly have not declined,
and this may reflect an underlying reluctance by physi-
cians to counsel and offer smoking cessation therapies
to the elderly. Bronchodilators and corticosteroids, the
most used medication for COPD, do not decrease mor-
tality in opposition to prolonged oxygen therapy, and
they are primarily used for symptom relief. However
they have a beneficial effect on QoL and exacerbation
rates. The choice of delivery devices for inhaled medica-
tions is important in the elderly, and patients’ should be
properly trained to a correct inhaler use and their dex-
terity should be frequently assessed. Pulmonary rehabili-
tation and nutritional supplementation are other
important components of the comprehensive care [3].
End-of-life issues should be adequately addressed in the
elderly with COPD and an approach integrating curative
and palliative interventions is strongly recommended.
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